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Medicine and the community
containing information about the number
of prescriptions dispensed by pharmacists
under the Pharmaceutical  Bene fi ts
Scheme.3 Similarly, the Bettering the Evalu-
ation and Care of Health (BEACH) pro-
gram,4 an annual survey of general practice








Objective:  To determine the extent of self-reported use of prescription medications in 
an Australian community sample.
Design, setting and participants:  Face-to-face interviews with a random, 
representative sample of the South Australian population (aged  15 years) living in 
metropolitan and rural areas. The study, a Health Omnibus Survey, was conducted 
een March and June 2004.
 outcome measures:  Reported number of prescribed medications used per 
n, most common categories of medication, and use by individuals of multiple 
ications for the same body system.
lts:  From 4700 households selected, 3015 participants were interviewed (65.9% 
nse rate). Of respondents, 46.8% were using prescribed medications; 171 
ndents (5.7%) were taking six or more medications, and four were taking 16 or 
more; 23.2% were using medications for the cardiovascular system, with 11.9% using 
agents acting on the renin–angiotensin system. Prescription medication use increased 
with age, with over 10% of respondents aged  55 years using six or more medications.
Conclusions:  Use of multiple prescribed medications was common, with the potential 
for significant drug interactions. Assuming a similar pattern of medication use Australia-
wide, reducing the number of prescribed medications by one for people taking six or 
MJA 2005; 183: 251–253
more medications would save the federal government about $380 million a year.he
of 
prT re has been increasing recognitionthe need to monitor the use ofescribed medications in the com-
munity to ensure the optimum use of finite
resources.1,2 The Drug Utilisation Sub-
Committee of the Pharmaceutical Benefits
Advisory Committee compiles a database
of medications prescribed to patients.
However, patient self-report data are not
routinely collated. Indeed, the most recent
Australia-wide survey of medication use
was conducted in the 1995 National Health
Survey.5 There have been surveys of medi-
cation use in nursing homes,6-8 and a
recent survey of an Australian Capital Terri-
tory community sample reported the use of
prescription, complementary and alterna-
tive medicines for the treatment of depres-
sion and anxiety.9 But we are unaware of
other Australian community surveys exam-
ining self-reported use of prescribed medi-
cations.
We report here the results of a survey of
current self-reported use of prescribed med-
ication in a random, representative sample of
the South Australian population aged 15 years
and over.
METHODS
Data were collected between March and
June 2004 using a Health Omnibus Survey
of both metropolitan and rural South Aus-
tralians at least 15 years of age. The Health
Omnibus Survey is a user-pays survey for
health organisations.10
The metropolitan sample was based on
the collectors’ districts used by the Austral-
ian Bureau of Statistics in the 2001 census.11
Ten dwellings were chosen in each district
by selecting every fourth household from a
random starting point. One face-to-face
interview was conducted per household
(when more than one person aged 15 or
over resided in a household, the respondent
was the person who last had a birthday).
The rural sample automatically included
all towns with a population of 10 000 or
more in the 2001 census, with the balance
selected from towns with a population of
over 1000. The methodology is described in
more detail elsewhere.12
The survey was conducted by experi-
enced health interviewers. For reliability
purposes, re-interviews for selected ques-
tions were conducted on a random 10% of
each interviewer’s work. Data were weighted
according to benchmarks derived from the
2001 census and 2002 estimated resident
population13 to provide estimates that
would represent the SA population in terms
of age, sex and region (metropolitan, non-
metropolitan).
Interviewers asked respondents whether
they were currently using any medications
prescribed by a general practitioner or medi-
cal specialist, including tablets, creams, sprays
and prescribed vitamins. Any non-doctor pre-
scribed preparations were excluded from the
analysis, as were oral contraceptives, as they
are usually not prescribed for ill health. Inter-
viewers collected demographic data and
recorded the number of prescribed medica-
tions reportedly taken by individual respond-
ents, but did not examine medication
containers or medicine cabinets.
Medication data were categorised using
the therapeutic index of the Pharmaceutical
Benefits Schedule.14 Use by individuals of
multiple medications for the same body
system was also examined.
RESULTS
Of the 4700 households selected, 127 were
found to be vacant dwellings. From the
remaining dwellings, 3015 interviews were
conducted (65.9% response rate). Reasons
for non-response were refusal to participate
(n=945), inability to establish contact after six
visits (n=366), language barrier (n=82), the
selected respondent being absent for the dura-
tion of the survey (n=58), illness (n=62),
inability to gain access to the dwelling (n=39)
and termination of the interview (n=6).JA • Volume 183 Number 5 • 5 September 2005 251
MEDICINE  AN D THE  COMMU NITYOf the 3015 respondents (49.1% male;
mean age, 45.3 years [SD, 18.9 years]),
1411 (46.8%) were taking one or more
prescribed medications (Box 1). The maxi-
mum number of prescribed medications
taken by any one respondent was 19, and
three others were taking 16 prescribed med-
ications. The use of multiple prescribed
medications increased with age.
The 10 most commonly reported categor-
ies of prescribed medication taken are
shown in Box 2.
The four body systems for which multiple
medication use was most common are
shown in Box 3. In addition to taking
medications from multiple classes of cardio-
vascular system medications, five respond-
ents were prescribed two different renin–
angiotensin system medications; seven were
taking two lipid-reducing agents; one was
taking two calcium-channel blockers; one
was taking two β-blockers; eight were taking
two diuretics (and three were taking three).
Of the respondents prescribed psychotropic
medications, three were taking two different
antidepressants. The number of respondents
using antidepressants included 111 (3.7%)
taking selective serotonin reuptake inhibi-
tors, 54 (1.8%) taking tricyclic antidepres-
sants, 25 (0.8%) taking venlafaxine and 14
(0.5%) taking other medications. There
were 54 (1.8%) people prescribed anxiolyt-
ics and 44 (1.5%) prescribed hypnotics.
DISCUSSION
It is difficult to compare the few surveys that
have been conducted on self-reported use of
prescription medications because of inter-
study differences in delineating the nature of
the prescribed medications, their classifica-
tion, and the time periods and subgroups
examined. For example, the 1995 National
Health Survey5 results were based on a 2-
week period of medication use in all age
groups, including those under 15 years;
another survey9 analysed data from three 5-
year age groups (20–24, 40–44 and 60–64
years) according to use in the previous
month. We utilised a point prevalence of
current use of prescribed medication among
people aged 15 years and older.
Notwithstanding these differences, our
results are consistent with the previous sur-
veys, particularly the 1995 National Health
Survey,5 which reported similar figures for
the number of medications used in the
different age groups.
Multiple medication use (polypharmacy)
was particularly apparent for the cardiovas-
cular and psychotropic medication groups.
However, it cannot necessarily be assumed
that any prescribing is inappropriate, as we
do not have clinical information about the
indications for prescription of individual
medications. Indeed, these figures highlight
the fact that the need for multiple medica-
tions increases with age. Thus, in the 55–
64-years age group, only a quarter of
respondents were not taking any prescribed
medication, and 14.8% of people aged 55
years and over were taking six or more
prescribed medications.
Nevertheless, bearing in mind the data
presented here, it is not surprising that
there have been community concerns about
the safe and effective use of medications and
that the federal government has responded
with programs such as the Home Medicines
Review, initiated in 2001.15 The program
was designed to review medications in peo-
ple who were regularly taking five or more
medications a day. It involves GPs and com-
munity pharmacists working together to
promote safe and effective medication use.
The program was introduced into the Medi-
care Benefits Schedule, but its uptake has
been slow.15 Our data suggest that there is
room for greater use of this initiative.
The large number of medications taken
by a minority of respondents in our study
is of concern, not only with regard to
appropriate prescribing, but also in relation
to potential drug interactions. The list of
medications used by one of the three
respondents who reported taking 16 pre-
scribed medications a day was as follows:
conjugated oestrogen; mycostatin; three
psychotropics (venlafaxine, chlorpro-
mazine and oxazepam); one anti-inflamma-
tory (diclofenac); four analgesics (two
different brands of oxycodone, tramadol
and paracetamol); and six medications for
the gastrointestinal system (pantoprazole,
docusate, atropine with diphenoxylate,
sorbitol, hyoscine and prochlorperazine). It
is quite probable that significant drug
interactions and drug-related symptoms
would be occurring in this person.
Such findings raise the ethical issue of
whether or not some form of intervention
should be offered in studies of this nature.
In preparing for this survey we had consid-
ered and planned for managing any distress




































































































































Agents acting on the renin–
angiotensin system
358 (11.9%)




Alimentary tract — drugs for 
acid-related disorders
252 (8.4%)
Antithrombotic agents 231 (7.7%)




β-blocking agents 159 (5.3%)
Calcium-channel blockers 158 (5.2%)
Diuretics 151 (5.0%)252 MJA • Volume 183 Number 5 • 5 September 2005
MEDICINE  AN D THE  COMMU NITYassociated with the data gathering, but had
not anticipated being confronted with such
extreme findings. Clearly, raising concerns
about polypharmacy would need to be
done sensitively, with due consideration of
the respondent and his or her medical
attendants.
It is pertinent to address the important
issue of the use of finite resources, particu-
larly in view of a recent government initia-
tive to reduce the price paid for medicines
under the Pharmaceutical Benefits Scheme.
The Prime Minister is reported to have
stated that such a plan would save taxpayers
about $740 million over 4 years.2 In our
study, 171 out of 3015 respondents were
taking six or more prescribed medications,
with an average of 7.8 medications per
person. If this was reduced by one pre-
scribed medication per person (and if we
assume that a prescription for each medica-
tion is issued once a month at an average
cost to the government of $35.84,16 and that
our SA results can be extrapolated to all
Australians aged  15 years), about $390
million could be saved nationally each year.
Although we can not necessarily assume
from a study of this nature that any medica-
tions are being inappropriately prescribed, it
is likely that at least some rationalisation
and reduction of prescribed medication use
could be achieved. Indeed, bearing in mind
that the above figure is only the government
cost, and does not include an individual’s
copayment, the potential savings to the
community would be far greater than
present government proposals are likely to
achieve.
A limitation of our study was that there
was only a 65.9% response rate, and it may
well be that those who agreed to participate
were more compliant with medication use
and had a greater familiarity with responses
to personal questions, thereby inflating the
figures we obtained. On the other hand,
respondents may not have reported all med-
ications used. Furthermore, nursing homes
and other residential care facilities, which
have a high use of medications,7,8 were not
included in our survey. Non-English speak-
ers were also excluded — potential medica-
tion-related problems of people from non-
English speaking backgrounds have been
referred to in other Australian studies.17
Notwithstanding these caveats, our sur-
vey not only demonstrates substantial pre-
scribed medication use in the community,
but also raises the possibility of significant
drug interactions. Furthermore, it provides a
basis for future comparisons, particularly
with regard to the potential for significant
cost savings by rationalising the number of
prescribed medications.
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3 Number (%) of participants using multiple medications for four different body 
systems (n= 3015)
Number of 
medications Cardiovascular Psychotropic Respiratory Musculoskeletal
1 279 (9.3%) 246 (8.2%) 115 (3.8%) 241 (8.0%)
2 213 (7.0%) 41 (1.4%) 73 (2.4%) 21 (0.7%)
3 110 (3.6%) 9 (0.3%) 25 (0.8%) 1 (0.0%)
4 67 (2.2%) 0 5 (0.2%) 0
5 20 (0.7%) 1 (0.0%) 2 (0.1%) 0
6 9 (0.4%) 0 0 0MJA • Volume 183 Number 5 • 5 September 2005 253
